


Integrated Electrophysiology & Behavioral Readouts for CNS Drug Development
Our CNS Platform offers a comprehensive suite of electrophysiological and behavioral tools — including EEG, LFP, evoked potentials, nerve conduction velocity, EMG, and fiber photometry — to characterize a wide range of CNS models. From theta–gamma phase–amplitude coupling (TG-PAC) as a translational biomarker for Alzheimer’s disease and neuropsychiatric drug evaluation, to LFP-based seizure quantification in the PTZ model, and objective sleep architecture analysis, our platform provides sensitive, mechanism-relevant readouts to support your CNS drug development.
Download the brochure to explore our full CNS capabilities and see how we can support your program.